Tilray Medical

Tilray Medical Announces Major Expansion of Medical Cannabis Portfolio in Australia

19 March 2026 -- New York, US and Sydney, Australia -- Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. today announced its largest portfolio expansion in Australia to date. The expanded medical cannabis offering reinforces Tilray Medical’s long-term commitment to the Australian market and supports increased patient...

Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market

11 March 2025 -- Neumünster, Germany -- Tilray Medical, a division of Tilray Brands, Inc and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the introduction of Tilray Craft, a new brand extension of the Tilray...